The CEO of Oramed Pharmaceuticals (ORMP), Nadav Kidron, says that the company is developing oral delivery solutions for drugs currently delivered via injection. It is also seeking to transform the treatment of diabetes through its proprietary lead candidate.
24 Mar 2021
Morning Trade Live
10 Nov 2020
The Watch List
15 Jan 2021
The Watch List
08 Feb 2021
The Watch List
04 Mar 2021
Market On Close
16 Mar 2021
The CEO of Oramed Pharmaceuticals (ORMP), Nadav Kidron, says that the company is developing oral delivery solutions for drugs currently delivered via injection. It is also seeking to transform the treatment of diabetes through its proprietary lead candidate.
24 Mar 2021